project on cancer of the rectum



Similar documents
The Belgian Dutch Clinical Pathway Network: CPs and knowledge sharing on the Importance of Continuous Quality Improvement

Immune priviledged sites and HSV resistance: experience of the Regavir platform. Ophtalmologica Brussels November 27th, 2014

Guide for Passengers with Reduced Mobility

National Bowel Cancer Audit Report 2008 Public and Executive Summary

Industrial Portfolio April 2015

June 11th The healthcare reform: How deep is the blue ocean? The US Ambassador s residence Rue Zinnerstraat Brussels

Smart Cities in Belgium

Switch-off plan (Afschakelplan / Plan de délestage)

CANCERS OF THE PERITONEUM PERITONEAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

BHS COMMITTEES MEETING 30 January 2014

How To Prepare A Meeting For A Health Care Conference

Belgisch marktleider administratieve ziekenhuissystemen

Bridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS

BRAZIL-LATINAM WELCOME OFFICE

Breast Cancer & Treatment in ACT and Surrounding Regions QUALITY ASSURANCE PROJECT. Five-year report

Bristol Hospital Cancer Care Center 2015 Annual Report

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines

The Impact of the Clinical Pharmacy in the Belgian Hospitals First conclusions of the national Pilot Project and prospectives

BREAST CANCER IN THE 21 st CENTURY. The Carolinas Medical Center NorthEast Experience. Garry Schwartz, MD

GENERAL SUMMARY AND DISCUSSION

Belgian Financial Intelligence Processing Unit

Update on the Belgian Cancer Registry,

Multidisciplinary team members views about MDT working:

Cancer Care Delivered Locally by Physicians You Know and Trust

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization N = 50

Below are some of the ways pathologists contribute to the six domains (listed in the order they appear on page 2 of the Strategy):

Certification protocol for breast screening and breast diagnostic services

MALIGNANT PLEURAL MESOTHELIOMA PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

Lung Cancer Multidisciplinary Meeting Toolkit. National Lung Cancer Working Group

Bijlage 1; Contactgegevens LoGO 1/5 BRUSSEL EN VLAAMS-BRABANT

Pancreatic Cancer: FDA Approved Treatments and Clinical Trials

Centre Jean Perrin. Centre de Lutte contre le Cancer d'auvergne CANCER CARE NETWORK

Working group «Education Formation»

JACIE in Belgium. Ivan Van Riet. National Jacie representative

On a consent form to be obtained for care abroad, a motivation can be included from two perspectives:

The evolution of rectal cancer therapy. Objectives

Colorectal Cancer Treatment

D 0349 final PROMOTING GOOD MEDICAL CARE

Breast Cancer Care & Research

How To Teach A Patient To Live With A Tumour

MANCHESTER Lung Cancer Screening Program Dartmouth-Hitchcock Manchester 100 Hitchcock Way Manchester, NH (603)

SUMMARY REPORT 2005 Survey of Hospital Physician Recruitment Trends

Standardisation of breast cancer pathology report. Gerd JACOMEN Pathology Breast Clinic AZ St Maarten Duffel/Mechelen Breast Clinic Voorkempen Malle

How To Know If You Have Cancer At Mercy Regional Medical Center

ITALCERT Istituto. Pagina 1 di 5. All fields are mandatory in order to be able to properly formalize and send the Certification agreement

Tricia Cox on 7/18/2012 at Oncology Center. Sarah Randolf. Female

Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

C a nc e r C e nter. Annual Registry Report

Preliminary Program. Orthopaedica Belgica. Autumn Course Osteotomy around the Knee.

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?

Surgical guidelines for the management of breast cancer

Addresses of offices and subsidiaries

A918: Prostate: adenocarcinoma

Inova. Breast Care Institute

.org. Metastatic Bone Disease. Description

Cancer in Ireland 2013: Annual report of the National Cancer Registry

ductal carcinoma in situ (DCIS)

Breast Health Program

Clinical Management Guideline Management of locally advanced or recurrent Renal cell carcinoma. Protocol for Planning and Treatment

How To Contact The Lung Cancer And Mesothelioma Multi-Disciplinary Team

Guidelines for Management of Renal Cancer

4.2 Spinal Cord Compression

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology

Lung Cancer Treatment Guidelines

Report of the database committee Improving the quality of care through better data registration.

The Role of the MDT Coordinator. Laura Throssell

Use of Guidelines for Treatment of Stage 3 Colon Cancer

How To Manage A Cancer Oncology Clinic

Cancer research in the Midland Region the prostate and bowel cancer projects

How common is bowel cancer?

Overview of Gynaecologic Cancer

Probe: Could you tell me about when?

GUIDELINES FOR ASSESSMENT OF SPINAL STABILITY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. CP57 Version: V3

CLINICAL ONCOLOGY MASTERCLASS IN April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME

AZ Sint Lucas - Brugge, Belgium

Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL

Evidence on the quality of medical note keeping: Guidance for use at appraisal and revalidation

CANCER TREATMENT PROGRAM

Transcription:

project on cancer of the rectum Newsletter 2010 is growing! We are pleased to send you this PROCARE newsletter. First of all, we would like to thank all the PROCARE-collaborators for their active participation within PROCARE: at the end of 2009, we reached the number of 3000 registrations. Figure 1 gives an overview of the registrations from October 2005, at the very beginning of the PROCARE project, until December 2009. all the participating centers to continue working with us in this interesting program. You can find the up-to-date list of participating hospitals further in the newsletter (Table 4). Thanks to the efforts of all participating hospitals, we were able to continue keeping the project on track. Presently, the TMEevaluation of candidate-trainers is finished, Cumulative frequency of registrations per quarter Content: Number of registrations 3000 2500 2000 1500 1000 500 0 2005.III 2005.IV 2006.I 2006.II 2006.III 2006.IV 2007.I 2007.II 2007.III 2007.IV 2008.I 2008.II 2008.III 2008.IV 2009.I 2009.II 2009.III 2009.IV 1 is growing! Figure 1. Cumulative frequency of registrations per quarter, October 2005 - December 2009 2 The TME-evaluation program will continue 2 Registrations within PROCARE 4 Urgent request to obtain relevant missing data 4 Towards risk adjusted benchmarking in the PROCARE project 5 PROCARE feedback 6 PROCARE web Although the PROCARE project contains a large amount of the rectal cancer patients in Belgium, there are still some gaps. Therefore, to increase the number of PROCAREcollaborators, two motivation letters were sent to the surgery departments of all hospitals in Belgium. The first letter was sent to the hospitals which did not yet participate in PROCARE, inviting them to join us. The purpose of the second letter was to motivate feedback has been given to the participating centers and the paper registration form has been updated. The new version will be used for cases submitted for PROCARE after 1st January 2010 and is available on the website of The Belgian Meanwhile, we also started with the at random TMEevaluation of the non-candidate trainers. Table 1 gives an overview of the evolutions within PROCARE. 7 PROCARE RX online application 8 PROCARE highlights Evolutions within PROCARE Past Present Future -- TME-evaluation of candidate-trainers -- Feedback to participating centers -- TME-evaluation of non candidate-trainers -- TME-teachings -- New registration form -- PROCARE Web application -- PROCARE RX application -- Individual feedback to the pathologists -- Radiotherapy Program Table 1. Past, present and future of the PROCARE project 1

The TME-evaluation program will continue The TME-evaluation program of candidatetrainers was finished in October 2009. This evaluation program resulted in 25 recognized PROCARE TME-trainers, 18 Dutchspeaking and 7 French-speaking surgeons. Today, surgeons can be trained with the assistance of these trainers for maximum 5 TME-surgeries. A remuneration of 525 e per case is provided for the PROCARE TME-trainer who will train his colleague. An important condition is - obviously - that these cases are submitted for registration in PROCARE. More information about the TME-trainings can be found on the website of the Belgian As planned, we recently started with the TME-evaluation of the non-candidate trainers. This part of the TME-evaluation program was somewhat delayed because of the large number of cases that was evaluated in the context of the TMEtraineeship. Nevertheless, we have started with the at random TME-evaluation of the non-candidate trainers in November 2009. For these TME-evaluations, we made an Registrations within PROCARE All patients treated in Belgium (inclusive palliative treatment) for invasive rectal carcinomas (all stages) can be registered within PROCARE. Remark that follow-up of the patient stops in case of local recurrence or metachronous distant metastasis. 1-20 21-50 51-130 130+ Not applicable in this area at random selection of all patients from all participating hospitals. The selection criteria are: (1) TME-cases (not PME!) from every participating hospital, minimum 1 case for each hospital, (2) cases from non-candidate trainers, and (3) date of surgery after July 2007 (this date will be changed, including also older cases). The at random TME-evaluation will be identical to the TME-evaluation of the candidate-trainers. This means that the Board of Pathologists performs the first review, while the Board of Surgeons takes the final decision. Note that in this process the material is completely anonymised by the Belgian No new TME-trainers will be nominated, but each surgeon still will get personal feedback on his or her evaluated cases. The at random TME-evaluation will continue at least until 2012. When patients are selected, the PROCARE data manager asks the pathologists for the requested material (Table 2), while the surgeons are informed by e-mail. Like mentioned in table 2, digital photos of the fresh specimen are necessary for the TME-evaluation. If it is not possible to bring the specimen in fresh condition to the pathologist lab, please take photos immediately after surgery. At the end of 2009, we reached the number of 3000 registrations. Figure 2 and figure 3 show the registration status in Belgium at the beginning of 2010. Males Females Not applicable in this area Material necessary for the TME-evaluations 1. Pathology protocol (report) and pathology report checklist after surgical resection (part of the PROCARE registration form) 2. Digital photos of the fresh TME-specimen before inking (ventral, dorsal) 3. Digital photos of the macrosections (after inking and fixation) and/or macro-slides (if available) 4. Micro-slides Table 2. Material necessary for the TMEevaluations At the end of October 2009, 70 from the 111 Belgian hospitals were participating in PROCARE. At that time, a letter was sent to 180 medical directors and surgeons (53 Dutch-speaking, 127 French-speaking) of 42 non-participating hospitals, inviting them to join us. We received spontaneous reactions from 14 different hospitals, coming from the head of the surgery department, surgeons, gastro-enterologists, oncologists or data-managers. The other 28 hospitals were contacted by the PROCARE data-manager with the help of Dr. C. Bertrand. A lot of hospitals showed their interest to register for PROCARE, in a retrospective and prospective way. Presently, 7 new hospitals (3 in Flanders, 4 in Wallonia) are involved in the PROCARE project, resulting in 77 participating hospitals. The most frequent reactions of the hospitals on call for PROCARE participation are listed in Table 3. A second letter was sent to centres that stopped or decreased their registration activity since January 2009. This letter was sent to 66 surgeons (38 in Flanders, 4 in Brussels and 24 in Wallonia) to stimulate them to continue with the registrations for PROCARE. Antwerpen -- AZ H. Familie Reet -- AZ Klina Brasschaat -- AZ Monica Deurne-Antwerpen -- AZ Sint-Augustinus Wilrijk -- AZ Sint-Elisabeth Herentals -- AZ Sint-Jozef Malle -- AZ Sint-Maarten Duffel-Mechelen -- AZ St-Dimpna Geel -- H. Hartziekenhuis Lier -- H. Hartziekenhuis Mol -- Imeldaziekenhuis Bonheiden -- Sint-Vicentiusziekenhuis Antwerpen- Mortsel -- Sint-Jozefkliniek Bornem Willebroek -- St. Elisabeth Turnhout -- St. Jozef Turnhout -- UZ Antwerpen -- ZNA Jan Palfijn Merksem -- ZNA Middelheim Antwerpen -- ZNA Stuivenberg Sint-Erasmus Antwerpen Brabant-Wallon -- Clinique Saint-Pierre Ottignies Brussel / Bruxelles -- CHIREC Bruxelles Autres sites -- CHU Brugmann Bruxelles -- Clinique Sainte-Anne Saint-Remi Bruxelles -- Cliniques de l Europe Bruxelles -- Hôpital Erasme Bruxelles -- Hôpital Universitaire Saint-Luc Bruxelles -- Institut Bordet Bruxelles -- Kliniek Sint-Jan Brussel -- UZ Brussel Hainaut -- Centre de Santé des Fagnes Chimay -- Centre Hospitalier de Jolimont- Lobbes La Louvière -- CHR de la Haute Senne Mons (=Soignies) -- Clinique Notre Dame Tournai -- Clinique Notre-Dame de Grâce Gosselies -- CHU de Charleroi -- CHU de Tivoli La Louvière -- CHR clinique Saint-Joseph-Hôpital De Warquignies Mons -- Hôpital André Vésale Montigny-le- Tilleul -- Réseau Hospitalier de Médicine Sociale Baudour Liège -- CHC Saint-Joseph Liège -- CH du Bois de l Abbaye et de Hesbaye Seraing -- CH Peltzer-La Tourelle Verviers Limburg -- CAZ Midden-Limburg Ziekenhuis Salvator Sint-Ursula -- CAZ Midden-Limburg Ziekenhuis Sint-Franciskus -- Maria Ziekenhuis Noord-Limburg -- Regionaal Ziekenhuis Sint-Trudo Sint-Truiden -- Virga Jesse Hasselt -- Ziekenhuis Oost-Limburg Luxembourg -- I H Famenne Ardenne Condroz Aye Most frequent reactions of hospitals on call for PROCARE participation 1. The participation will be discussed on moc meetings in the hospital, with gastro-enterologists and pathologists. 2. The guidelines were already followed, but there is no time to do the registrations. 3. The registrations are ready to be sent to the Belgian Table 3. Most frequent reactions on call for participation We hope these two letters will help to increase the number of registrations during the following months. We estimate that a large part of all the rectal cancers is still missing in the database of PROCARE. Namur -- Clinique Sainte-Elisabeth Namur -- Cliniques Universitaires de Mont- Godinne Oost-Vlaanderen -- Algemeen Stedelijk Ziekenhuis Aalst -- AZ Jan Palfijn Gent -- AZ Maria Middelares Gent -- AZ Oudenaarde -- AZ Sint-Elisabeth Zottegem -- AZ Zusters Van Barmhartigheid Ronse -- OL Vrouwziekenhuis Aalst-Asse-Ninove -- Sint-Vicentiusziekenhuis Deinze -- UZ Gent Vlaams-Brabant -- AZ Diest -- AZ Jan Portaels Vilvoorde -- Regionaal Ziekenhuis Heilig Hart Leuven -- Regionaal Ziekenhuis Heilig Hart Tienen -- UZ Leuven West-Vlaanderen -- AZ Groeninge Kortrijk -- AZ Sint-Jan Brugge -- AZ Sint-Lucas Brugge -- Gezondheidszorg Oostkust -- H.-Hartziekenhuis Roeselare-Menen -- Henri Serruys Ziekenhuis AV Oostende -- OLV Lourdes Waregem -- Regionaal Ziekenhuis Jan Yperman Ieper -- Stedelijk Ziekenhuis Roeselare -- Sint-Andriesziekenhuis Tielt -- Sint-Augustinuskliniek Veurne -- Sint-Jozefskliniek Izegem Figure 2. Overview of the number of PROCARE registrations in Belgium by residence hospital and by district, status at the beginning of 2010 Figure 3. Overview of the number of PROCARE registrations in Belgium by sex, by residence hospital and by district, status at the beginning of 2010 Table 4. List of participating hospitals, status on 01/02/2010 2 3

Urgent request to obtain relevant missing data PROCARE Feedback In search for better and more objective methods for benchmarking and feedback, the anonymised PROCARE databank will be used and tested in May 2010. Knowing your results is essential. Missing relevant data need to be reduced to a minimum. Therefore, the PROCARE datamanagers did a major effort and sent you by the end of February 2010 an Excel file with the list of your registered patients asking to fill in missing relevant information. Additional information only was asked for those patients of whom it is missing in the database. Also, the number of requested data was limited to those related to disease free survival (i.e. local recurrence or metachronous metastasis), to essential data on (neo)adjuvant chemotherapy and to adjuvant radio(chemo)therapy for pstage II and III patients. A reminder will be sent at the end of March and mid April 2010 if the additional information on your patients in the PRO- CARE database would not have reached the datamanagers by then. No doubt, you will understand that this additional effort is needed for being able to give you better feedback with more objective and adapted benchmarking by the end of 2010. At this occasion, but equally so at any time, your team can add forms of patients that have been treated but not yet registered. The more patients are registered, the better the quality of the feedback. Note that cstage IV i.e. patients with metastatic disease are an important part of the target patient population of the project. Their forms should also be submitted for registration. The feedback was given to the participating hospitals at the end of 2009. It was based on 2439 patients in total, distributed over 70 hospitals. In the new feedback report, a number of indicators were added, others were recalculated and the layout of the report was adapted to make it more coherent than the feedback of 2008. You can find some key tables in Table 5, 6 and Figure 4 from the PROCARE feedback 2009. More information can be found on the website of the Belgian Technique of resection Frequency Percent Cumulative Frequency Cumulative Percent PME 342 14,0 342 14,0 TME 1793 73,5 2135 87,5 Conventional 22 0,9 2157 88,4 Missing 282 11,6 2439 100,0 Table 5. Overview of the techniques used for resection Type of reconstruction Frequency Percent Cumulative Frequency Cumulative Percent Polypectomy 1 0,04 1 0,04 Towards risk adjusted benchmarking in the PROCARE project In the PROCARE project, a set of 41 quality of care indicators (QCI) for the management of rectal cancer has been identified. More than 130 variables per patient are prospectively registered. The ultimate goal of these major efforts is to improve clinical, multidisciplinary performance, i.e. outcome of the patients, by standardisation of staging, treatment and follow-up, and by detection and change in case of suboptimal performance. This goal can only be reached if the data are summarized and communicated in an appropriate way, including risk adjustment, control of data quality and evaluation of progress. Some colleagues may still be reluctant about audit. However, quality assessment of health care has become an essential, sometimes challenging aspect of clinical practice. Professionals should accept this challenge and take responsibilities, supported by methodological experts. In his meeting of April 2009 the PROCARE Steering Group decided to collaborate with a group of statisticians and to submit a joint candidature for a study at the KCE on Methods for benchmarking prospectively registered quality indicators of cancer treatment what was done in May and accepted by the KCE. The aims of this study are the following: 1. Which characteristics (risk factors) need to be taken into account to obtain a fair evaluation of the performance of individual teams (QCI) in the treatment of (rectal) cancer? 2. How can various outcome and processrelated QCIs be combined? 3. How can a statistical approach based on mixed-model methodology provide a sound basis for such evaluation (also in low-volume centers)? 4. Which quantifications should be the key elements in the feedback to the individual teams (position relative to other teams or to absolute quality standards; changes in performance over time)? Presently, PROCARE offers feedback and benchmarking with reference to the median performance. More improvement is possible by referring to the best clinical practices. Alternatively, targets can be predetermined by multidisciplinary peers. It is expected that with this new initiative an atmosphere of striving for optimal results will be created, based on confidential audit with risk-adjusted feedback. A scientific approach agreed upon by clinicians and statisticians is a prerequisite. The methodology will be tested on about 3000 patients registered in the PROCARE database. Evidently, the strict confidentiality rules, the multidisciplinary, decentralised, and educational nature of the PROCARE project will be respected. With risk adjustment, feedback and benchmarking will not only be more credible but also more stringent. In case of suboptimal performance, teams will have to recognize the facts, plan and take actions with re-evaluation at a relatively short interval, provided by PROCARE. Arrangements are being taken so that optimal feedback and benchmarking will continue after this study till the end of the project (and possibly beyond). Text written by The PROCARE Steering Group A number of remarks are noteworthy. First, for some indicators we were confronted with a large number of missing data (for instance ASA, TME quality, dates of biopsy and radiotherapy, adjuvant chemotherapy). Second, there are still some problems with the use of the report sheet; some teams still use a dated version of the report sheet, others create their own sheet, without including all necessary information. Therefore, we suggest in the future to use the online application, or - at least - use the most recent version of the PROCARE data entry form (new version since 01/01/2010 can be found on the website of the Belgian Cancer Registry). Finally, from 2010 on, we are aiming at giving feedback twice a year, one intermediate short feedback in the middle of the year (June-July) and one complete feedback at the end of the year (December). More information can be found on the website of the Belgian Local excision 12 0,49 13 0,53 TEM 16 0,66 29 1,19 APER 432 17,71 461 18,90 Hartmann 62 2,54 523 21,44 HAR + CRA 53 2,17 576 23,62 LAR + CRA 423 17,34 999 40,96 TME + straight 412 16,89 1411 57,85 TME + Pouch 477 19,56 1888 77,41 TME + Coloplasty 42 1,72 1930 79,13 TME + Other 242 9,92 2172 89,05 Other techniques 14 0,57 2186 89,63 Missing 253 10,37 2439 100,00 Table 6. Overview of the types of reconstruction Survival Probability 0.0 0.2 0.4 0.6 0.7 0.8 1.0 Observed survival by (y)pstage (N=1815) 0 (N= 131) I (N= 403) II (N= 422) III (N= 439) IV (N= 249) Missing (N= 171) 0 8 12 18 24 Time (months) Figure 4. Overall overview of the observed 2 year survival (Kaplan-Meyer Curve) 4 5

PROCARE web PROCARE RX online application The PROCARE web application is currently in its final test phase. In the future, online registration will be the preferred means of registration. It is expected that the PROCARE web application will be operational at the beginning of 2010. In order to use it, you will need to possess a token or an eid (electronic Belgian ID card) together with its reader and its pin. We can help you with the procedure of obtaining an eid card reader. We will also provide you with a user manual in which all the steps about how to use the application are explained. The manual and more information will be found at the website of the Belgian In order to receive access to the PROCARE web application, a personal user account has to be created. The system of Lokale Beheerders (LB) Gestionnaires Locaux (GL) by ehealth is widespread through Belgian hospitals and will be used. The LB GL can give access to persons who will use the online application. The use of the PROCARE web application will ask some efforts. On the other hand, a number of benefits, compared to the paper version, will be offered. First, every specialist will have the opportunity to fill in the chapter of his or her speciality. The status of each chapter will be visible for every specialist who is involved to this specific registration form. The usability of the application will support the multidisciplinary character of the PROCARE project. There will be a distinct overview of all cases registered thanks to the use of a work list. Second, data are transferred directly to the Belgian Cancer Registry, which makes the transfer easy and safe. Third, it will be more difficult to make mistakes when filling out the registration form, due to the limitation in answering options, often defined by previous answers. This will result in a database with a higher quality of data and consequently with more reliable results. Some screens of the PROCARE web application are shown in figure 5, 6 and 7. PROCARE RX will make it possible for the radiologists to ask for an anonymous second opinion on ctn and ccrm, based on CTscan and MRI-images of the pelvis. The PROCARE RX application is the first of its kind in Belgium. It will be a unique project which can be very useful for every radiologist who wants a second and anonymous opinion of CT- and/or MRI-images. In case of discordance between the local radiologist and the expert radiologist, a second review will occur. The process stops here, no third review will be possible. A team of expert radiologists was indicated by the Royal Belgian Society of Radiology. They will review these images at random and in an anonymous way to assess quality and reliability of the interpretation. The PROCARE RX online application will be operational in the beginning of 2010. Security and web accessibility issues are identical for both the PROCARE web application and the PROCARE RX online application: the system of Lokale Beheerders (LB) Gestionnaires Locaux (GL) by ehealth will create the access to the platform. Some opening screens of the PROCARE RX application are shown in figure 8, 9 and 10. Figure 5. When logging-in to PROCARE web, the user-permissions will be checked. Figure 6. Homescreen, view from the Responsible Specialist. Figure 8. When choosing your profile, your permissions will be checked. Figure 9. Homescreen, point of view from Expert Radiologist/ Reviewer. Figure 7. The registration form consists of 6 different chapters plus follow-up. Figure 10. Worksheet when asking for a second anonymous opinion. 6 7

PROCARE Highlights New PROCARE Registration form The new PROCARE registration form will be used for cases submitted since 1st January 2010 (prospective and retrospective registration). The updated version can be found on the website of the Belgian Request for missing data follow-up Requests for missing data were sent at the beginning of 2010 individually per center. These are mostly but not only chemotherapy, radiotherapy and follow-up forms. We kindly ask you to send the missing parts for your registered patients in case you have not yet done so. Thank you for your efforts. Feedback to pathologists We are in the process of organizing individual feedback to the pathologists based on the pathological material, checklists and reports received. This will be sent out individually in the course of the following months. Radiotherapy An online communication platform (AQUI- LAB software) will be created between the departments of Radiation Oncology. The purpose is to exchange contours delineated on the dosimetric CT scan and to perform a central review. In that way, the target volume of pre-operative irradiation will be homogenized by comparing the volumes proposed by each hospital to a central atlas. Attendance to congresses PROCARE was represented at the Belgian Week of Gastroenterology (February 2009, Antwerp) and at the Belgian Surgical Week (April 2009, Oostende). We look forward to represent PROCARE again in 2010. Please send us all your remarks and comments! We are always ready to help you. project on cancer of the rectum Stichting Kankerregister Registre du Cancer Koningsstraat / Rue Royale 215 1210 BRUSSEL / BRUXELLES België / Belgique Tel. +32 (0)2 250 10 17 Fax +32 (0)2 250 10 11 procare2@kankerregister.org procare2@registreducancer.org www.kankerregister.org, submenu PROCARE www.registreducancer.org, submenu PROCARE Tamara Vandendael and Koen Beirens are working at the BCR for PROCARE. With financial support of: 8